Suppr超能文献

相似文献

1
From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.
J Clin Oncol. 2015 Nov 1;33(31):3583-90. doi: 10.1200/JCO.2015.62.4148. Epub 2015 Aug 24.
6
Survival end point reporting in randomized cancer clinical trials: a review of major journals.
J Clin Oncol. 2008 Aug 1;26(22):3721-6. doi: 10.1200/JCO.2007.14.1192.

引用本文的文献

2
Trends of Publication of Negative Trials Over Time.
Clin Pharmacol Ther. 2025 Mar;117(3):818-825. doi: 10.1002/cpt.3535. Epub 2025 Jan 5.
4
Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials.
JAMA Netw Open. 2023 May 1;6(5):e2313819. doi: 10.1001/jamanetworkopen.2023.13819.
5
Design and reporting of phase III oncology trials with prospective biomarker validation.
J Natl Cancer Inst. 2023 Feb 8;115(2):174-180. doi: 10.1093/jnci/djac210.
6
Usefulness of Cochrane Reviews in Clinical Guideline Development-A Survey of 585 Recommendations.
Int J Environ Res Public Health. 2022 Jan 7;19(2):685. doi: 10.3390/ijerph19020685.
7
An urgent call to raise the bar in oncology.
Br J Cancer. 2021 Nov;125(11):1477-1485. doi: 10.1038/s41416-021-01495-7. Epub 2021 Aug 16.
8
Public access to protocols of contemporary cancer randomized clinical trials.
Trials. 2021 Jun 27;22(1):418. doi: 10.1186/s13063-021-05382-7.
9
Rethinking clinical oncology drug research in an era of value-based cancer care: A role for chemotherapy pathways.
Cancer Med. 2020 Aug;9(15):5306-5311. doi: 10.1002/cam4.3193. Epub 2020 Jun 10.
10

本文引用的文献

1
Compliance with results reporting at ClinicalTrials.gov.
N Engl J Med. 2015 Mar 12;372(11):1031-9. doi: 10.1056/NEJMsa1409364.
2
The proposed rule for U.S. clinical trial registration and results submission.
N Engl J Med. 2015 Jan 8;372(2):174-80. doi: 10.1056/NEJMsr1414226. Epub 2014 Dec 24.
3
Social science. Publication bias in the social sciences: unlocking the file drawer.
Science. 2014 Sep 19;345(6203):1502-5. doi: 10.1126/science.1255484. Epub 2014 Aug 28.
5
Research: increasing value, reducing waste - Authors' reply.
Lancet. 2014 Mar 29;383(9923):1126-7. doi: 10.1016/S0140-6736(14)60563-8.
6
Why publishing everything is more effective than selective publishing of statistically significant results.
PLoS One. 2014 Jan 17;9(1):e84896. doi: 10.1371/journal.pone.0084896. eCollection 2014.
7
SPIRIT 2013 statement: defining standard protocol items for clinical trials.
Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.
8
Multiplicities in cancer research: ubiquitous and necessary evils.
J Natl Cancer Inst. 2012 Aug 8;104(15):1124-32. doi: 10.1093/jnci/djs301. Epub 2012 Aug 2.
10
Comparison of protocols and registry entries to published reports for randomised controlled trials.
Cochrane Database Syst Rev. 2011 Jan 19;2011(1):MR000031. doi: 10.1002/14651858.MR000031.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验